Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 100,000 shares at $5.00 ($500K) on 2024-12-16, disclosed to the SEC on 2024-12-18.
Scheduled sale ($500k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RLAY | SELL | 2026-08-18 | $980K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |